ProteoMediX's Series B Round

ProteoMediX raised a round of funding on April 09, 2014.

ProteoMediX is a spinoff company of ETH Zurich and specializes in the identification of biomarkers for the early detection of cancer and the personalized treatment thereof. The first product currently…

Articles about ProteoMediX's Series B Round: